<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>BiotechVentureCapital | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T11:32:23+08:00</updated>
  <subtitle>Biotech领域投资心得分享</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>CKD漫谈：How hard it can be？</title>
    <updated>2020-12-27T18:48:43+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/4sdOW7kovgC-MD5QYeB2Pg</id>
    <link href="https://mp.weixin.qq.com/s/4sdOW7kovgC-MD5QYeB2Pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>颠覆式创新：小分子PD-L1抑制剂能否破解PPI靶点成药难题？</title>
    <updated>2020-12-13T23:44:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/gajrpLmqTSkABKdPboGF5g</id>
    <link href="https://mp.weixin.qq.com/s/gajrpLmqTSkABKdPboGF5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>蓦然回首，灯火阑珊处</title>
    <updated>2020-12-09T07:54:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/emQBY32juipldUqrKp60uA</id>
    <link href="https://mp.weixin.qq.com/s/emQBY32juipldUqrKp60uA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>不一样的CDK4/6抑制剂</title>
    <updated>2020-08-12T08:54:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-12:/s/l4iA9UVczPQeGlSlF9Jjmw</id>
    <link href="https://mp.weixin.qq.com/s/l4iA9UVczPQeGlSlF9Jjmw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20位新药创始人：中国First in class新药的开发之路</title>
    <updated>2020-08-12T08:54:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-12:/s/9liLtdNnc4wPJ7Ir0UUH8A</id>
    <link href="https://mp.weixin.qq.com/s/9liLtdNnc4wPJ7Ir0UUH8A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>二代BTK开发热潮下的冷思考</title>
    <updated>2020-06-30T10:16:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-06-30:/s/HBU7D3o7c9jaScNb3qcH0Q</id>
    <link href="https://mp.weixin.qq.com/s/HBU7D3o7c9jaScNb3qcH0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>相似的路,不同的结果</title>
    <updated>2020-06-11T09:18:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-06-11:/s/OEq-TWorT-AN0G-PiTKU2w</id>
    <link href="https://mp.weixin.qq.com/s/OEq-TWorT-AN0G-PiTKU2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​江苏新元素医药完成约3000万美金B轮融资</title>
    <updated>2020-05-27T08:48:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-05-27:/s/FMpoHX8yZzmOebWoTdUWqg</id>
    <link href="https://mp.weixin.qq.com/s/FMpoHX8yZzmOebWoTdUWqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>液液相分离，未来的</title>
    <updated>2020-03-17T11:31:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-03-17:/s/3PbB5Eu1g7-Du_OSy6fGTw</id>
    <link href="https://mp.weixin.qq.com/s/3PbB5Eu1g7-Du_OSy6fGTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于IBD领域立项的深入思考</title>
    <updated>2020-03-09T09:14:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-03-09:/s/gaVknf0AAjdPpZppEM9xbw</id>
    <link href="https://mp.weixin.qq.com/s/gaVknf0AAjdPpZppEM9xbw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>燃烧吧，小宇宙：Driver Antigen Engagement</title>
    <updated>2020-03-02T09:24:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-03-02:/s/DR4E7yxOdJ3oLB47P_XA9g</id>
    <link href="https://mp.weixin.qq.com/s/DR4E7yxOdJ3oLB47P_XA9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>